Management of plexiform neurofibroma with interferon alpha

Pediatric Hematology and Oncology

Volumn 25, Issue 7, 2008, Pages 673-678

  Citak, Elvan Caglar ^a,b   Oguz, Aynur ^a   Karadeniz, Ceyda ^a   Okur, Arzu ^a   Memis, Leyla ^a   Boyunaga, Oznur ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Department of Pathology ^*  (Turkey)

Author keywords

Child; Interferon alpha; Neurofibromatosis type 1; Plexiform neurofibroma

Indexed keywords

ALPHA INTERFERON;

ANAMNESIS; ARTICLE; CAFE AU LAIT SPOT; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; EYE EXAMINATION; FOLLOW UP; GASTROCNEMIUS MUSCLE; GENERAL CONDITION IMPROVEMENT; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; LEG SWELLING; MALE; MEDICAL EXAMINATION; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEXIFORM NEUROFIBROMA; PRESCHOOL CHILD; TISSUE SECTION; TUMOR BIOPSY;

CHILD; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; MALE; NEUROFIBROMA, PLEXIFORM;

EID: 53749102450     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010802315983     Document Type: Article

References (20)

1. Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997;278:51-57.
2. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty-first century perspective. Lancet Neurol. 2007;6:340-351.
3. Tonsgard JH. Clinical manifestation and management of neurofibromatosis type 1. Semin Pediatr Neurol. 2006;13:2-7.
4. Greinwald J, Derkay CS, Schechter GL. Management of massive head and neck neurofibromas in children. Am J Otolaryngol. 1996;17:1326-1342.
5. Packer RJ, Rosser T. Therapy for plexiform neurofibromas in children with neurofibromatosis 1: an overview. J Child Neurol. 2002;17:638-641.
6. Korf BR. Plexiform neurofibromas. Am J Med Genet. 1999;89:31-37.
7. Hajdu SI. Peripheral nerve sheath tumors. Histogenesis, classification and prognosis. Cancer. 1993;72:3549-3552.
8. Kluwe L, Reinhard FE, Mautner VF. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet. 1999;113:65-69.
9. Rassmussen SA, Overman J, Thomson SA, et al. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type I. Genes Chromosomes Cancer. 2000;28:425-431.
10. Huson SM, Harper PS, Compston AS. Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales. Brain. 1988;111:1355-1381.
11. Tonsgard JH, Kwak SM, Short P, Dachmann AH. CT imaging in adults with neurofibromatosis 1: frequent asymptomatic plexiform lesions. Neurology. 1998;50:1755-1760.
12. Koper JW, Zwarthoff EC, Hagemeijer A, et al. Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha. Eur J Cancer. 1991;27:416-419.
13. Packer RJ, Gutmann DH, Rubenstein A, et al. Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology. 2002;58:1461-1470.
14. Jiang CL, Son LX, Lu CL, et al. Analgesic effect of interferon-alpha via mu opioid receptor in the rat. Neurochem Int. 2000;36:193-196.
15. Wang JY, Zeng XY, Fan GX, Yuan YK, Tang JS. mu- but not delta- and kappa-opioid receptor mediates the nucleus submedius interferon-alpha-evoked antinociception in the rat. Neurosci Lett. 2006;397:254-258.
16. Kebudi R, Ayan I. Interferon-alpha for neurofibromas. Med Pediatr Oncol. 1996;26:220-222.
17. Babovic-Vuksanovic D, Widemann BC, Dombi E, et al. Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas. Pediatr Neurol. 2007;36:293-300.
18. Babovic-Vuksanovic D, Ballman K, Michels V, et al. Phase II trial of pirfenidone in adults with neurofibromatosis type 1. Neurology. 2006;67:1860-1862.
19. Gupta A, Cohen BH, Ruggieri P, Packer RJ, Phillips PC. Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1. Neurology. 2003;60:130-132.
20. Baujat B, Krastinova-Lolov D, Blumen M, Baglin AC, Coquille F, Chabolle F. Radiofrequency in the treatment of craniofacial plexiform neurofibromatosis: a pilot study. Plast Reconstr Surg. 2006;117:1261-1268.